A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

ClinicalTrials.gov ID: NCT00479765

Public ClinicalTrials.gov record NCT00479765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT00479765
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Boston Scientific Corporation; Industry
Enrollment: 4 participants

Conditions and interventions

Conditions

Interventions

OncoGel (ReGel/Paclitaxel) Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 28, 2007
Primary completion: Sep 30, 2009
Completion: Sep 30, 2009
Last update posted: Jun 21, 2022

2007 – 2009

United States locations

U.S. sites: 5
U.S. states: 5
U.S. cities: 5

Facility	City	State	ZIP	Site status
The University of Chicago Brain Tumor Center	Chicago	Illinois	60637	—
The Johns Hopkins University	Baltimore	Maryland	21231	—
University of Rochester Medical Center	Rochester	New York	14642	—
University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27599	—
Vanderbilt University Medical Center	Nashville	Tennessee	37212	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00479765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 21, 2022 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00479765 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →